Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI.
Graham comments: "’m excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout my career in health economics and market access, I’ve been passionate about bringing meaningful innovations to patients and healthcare systems.
“Having been at Olympus Corporation for nearly ten years working across Global Systems and a wide variety of therapies, this role allows me to focus on a deeper understanding of patient impact in the speciality area of opthalmics alongside the opportunity to work with Glaukos’ portfolio which is uniquely positioned to improve outcomes while addressing real-world access and reimbursement challenges.
“The company’s forward-thinking approach to evidence generation, health policy and value creation strongly aligns with my drive to ensure innovative ophthalmic solutions reach the patients and clinicians who need them most.”
FURTHER INFORMATION:
Glaukos
W: www.glaukos.com/en-uk/
